PDK1 (Phosphoinositide-dependent kinase-1) also known as PDPK1 (3-phosphoinositide dependent protein kinase-1) is a serine/threonine protein kinase, which functions as a master kinase to phosphorylate and activate a subgroup of the AGC family kinases such as PKB/Akt, PKC, S6K, SGK, and RSK, thus, playing a pivotal role in the PI3K/Akt signaling pathway.
PDK inibitori (PDK Inhibitors)
| N. Cat. | Nome del prodotto | Informazioni | Citazioni di utilizzo del prodotto | Validazioni del prodotto |
|---|---|---|---|---|
| S1274 | BX-795 | BX-795 è un potente e specifico inibitore di PDK1 con un IC50 di 6 nM, 140 e 1600 volte più selettivo per PDK1 rispetto a PKA e PKC in saggi acellulari, rispettivamente. Nel frattempo, in confronto a GSK3β, è stata osservata una selettività oltre 100 volte superiore per PDK1. BX-795 modula l'autophagy inibendo ULK1. BX-795 è anche un potente inibitore di TBK1 che blocca sia TBK1 che IKKε con valori di IC50 di 6 nM e 41 nM, rispettivamente. |
|
|
| S0983 | JX06 | JX06 è un inibitore covalente selettivo di PDK1 nelle cellule. Questo composto inibisce PDK1, PDK2 e PDK3 in modo dose-dipendente con IC50 di 0,049 μM, 0,101 μM e 0,313 μM, rispettivamente. |
|
|
| S8615 | Sodium Dichloroacetate (DCA) | Il DCA (Sodium Dichloroacetate), un inibitore specifico della piruvato deidrogenasi chinasi (PDK) con valori di IC50 di 183 e 80 μM rispettivamente per PDK2 e PDK4, ha dimostrato di dereprimere il cotrasportatore Na+-K+-2Cl- e un asse del canale ionico del potassio mitocondriale. Il Sodium Dichloroacetate aumenta la generazione di specie reattive dell'ossigeno (ROS), innesca l'apoptosi nelle cellule tumorali e inibisce la crescita tumorale. |
|
|
| S2949 | KPLH1130 | KPLH1130 è un inibitore specifico della piruvato deidrogenasi chinasi (PDK) che blocca la polarizzazione dei macrofagi e attenua le risposte proinfiammatorie. |
PDK1 protein is composed of two well-characterized functional domains: (1) the N-terminal serine/threonine kinase domain of the AGC family, and (2) the C-terminal Pleckstrin homology (PH) domain that interacts with high affinity with both PtdIns(3,4,5)P3 and PtdIns(3,4)P2 as well as other phosphoinositides such as PtdIns(4,5)P2. PDK1 is ubiquitously expressed and constitutively active in mammalian cells. In addition to being able to constitutively phosphorylate substrates, PDK1 also works in an inducible manner in response to specific stimuli. Without stimuli, the catalytic activity of PDK1 is kept under control by limiting its access to targets, whereas upon stimulation, the different PDK1 substrates are converted into forms that can be recognized, phosphorylated and activated by PDK1. PDK1 regulates as much as 23 growth-factor-stimulated AGC kinases, containing protein kinase B (PKB/Akt) isoforms, p70 ribosomal protein S6 kinase (S6K) isoforms, p90 ribosomal protein S6 kinases (RSK), serum- and glucocorticoid-induced protein kinase (SGK) isoforms, and several protein kinase C (PKC) isoforms, by phosphorylating at the serine/threonine residues in their T-loop. [1]
The autophosphorylation of PDK1 at Ser241 in the T-loop or activation loop contributes to the catalytic activity of PDK1 upon substrate binding, and several other phosphorylation sites have also been proposed to contribute to the regulation of PDK1 activity. Upon growth factor stimulation and PtdIns(3,4,5)P3 production, both PKB/Akt and PDK1 translocate to the plasma membrane via the specific interaction of their PH domains with newly generated PtdIns(3,4,5)P3, where PDK1 could then readily phosphorylate and activate PKB/Akt, allowing PKB/Akt to phosphorylate downstream targets such as Foxo1. The mTORC1 or mTORC2 mediated phosphorylation of the hydrophobic motif of AGC kinases is essential for PDK1-mediated activation. This is achieved by creating a docking site for the binding of PDK1 to facilitate the phosphorylation of the kinases at its T-loop by PDK1. Moreover, the interaction of the hydrophobic motif binding pocket (PIF pocket) of PDK1 with the phosphorylated hydrophobic motif in the substrate induces the allosteric activation of PDK1. [1]
Therefore, through targeting a particular set of these AGC kinases, PDK1 play a critical role in regulating a wide variety of physiological processes including cell growth, proliferation, survival, development, and metabolism. PDK1 knockout mice die during early embryonic development, and the PDK1 dominant negative mutants knock-in mice are also shown to be embryonically lethal. A series of tissue-specific conditional knockout mice lacking PDK1 also confirm both the implication of PDK1 in mediating metabolic responses to insulin as well as in promoting cell viability, which proposes that selective activation of PDK1 might be a good strategy for the treatment of diabetes. However, PDK1 overexpression and amplification of the PDK1 gene are common occurrences in breast cancer and acute myeloid leukaemia. PDK1 also displays an epistatic relationship with the lipid phosphatase PTEN in the migration and malignant transformation of lymphocytes and in regulating nervous system development. Moreover, PTEN heterozygous mice expressing reduced levels of PDK1 are markedly protected from developing a wide range of tumors, indicating that PDK1 is a key effector in mediating tumorigenesis resulting from loss of PTEN and further validating PDK1 as a valuable anticancer target for the development of specific inhibitors. [1]
I prodotti sono solo per uso di ricerca. Non per uso umano. Non vendiamo a pazienti.
©Copyright 2013 Selleck Chemicals. Tutti i diritti riservati.